NCT05851066
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Hyperlipoproteinemia Type II
Explore clinical trials studying Hyperlipoproteinemia Type II. Study availability and eligibility vary by location and protocol.
176 public trials
32 recruiting studies
Hyperlipoproteinemia Type II trial results
NCT05181553
- Conditions
- Cardiovascular Diseases, Cholesterol, Elevated, Cholesterol; Metabolic Disorder, +14 more
- Locations
-
- Institute on nutrition and functional foods, Laval University Québec, Quebec, Canada
NCT05952856
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
- Locations
-
- Alliance for Multispecialty Research, LLC ( Site 0093) Daphne, Alabama, United States
- G&L Research ( Site 0043) Foley, Alabama, United States
- Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084) Phoenix, Arizona, United States
- National Heart Institute-Research ( Site 0087) Beverly Hills, California, United States
NCT07023445
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
NCT05425745
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +14 more
- Locations
-
- Site 01022 Jonesboro, Arkansas, United States
- Site 01015 Toluca Lake, California, United States
- Site 01009 Sarasota, Florida, United States
- Site 01023 Boise, Idaho, United States
Completed
Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
NCT03110432
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Dyslipoproteinemias, +14 more
- Locations
-
- Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Germany
- Innere Medizin IV - Diabetologie, Endokrinologie und Nephrologie am Universitaetsklinikum Tübingen, Germany
- Nephrologisches Zentrum Villingen-Schwenningen, Germany
Completed
A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease
NCT05398029
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +16 more
- Locations
-
- Clinical Study Center Auckland, New Zealand
- Clinical Study Center Christchurch, New Zealand
- Clinical Study Center London, United Kingdom
Completed
Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels
NCT06910098
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Central Park Teaching Hospital Lahore, Pakistan
NCT05261126
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
- Locations
-
- Westside Medical Associates of Los Angeles ( Site 0026) Beverly Hills, California, United States
- Clinical Trials Research ( Site 0007) Sacramento, California, United States
- National Research Institute (NRI) - Santa Ana ( Site 0024) Santa Ana, California, United States
- Excel Medical Clinical Trials ( Site 0042) Boca Raton, Florida, United States
NCT02808403
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
- Locations
-
- Research Site Ichinomiya, Aichi-ken, Japan
- Research Site Ichinomiya, Aichi-ken, Japan
- Research Site Inuyama, Aichi-ken, Japan
- Research Site Kasugai, Aichi-ken, Japan